Abstract
Our present study provided new evidence for diterbium transferrin (Tb(2)Tf) as a potential multi-photon-excited microscopy probe. It indicated that the Tb(2)Tf complex can be transported into human leukemia K562 cells via a process mediated by transferrin (Tf) receptors as an intact entity and with no obvious cellular toxicity. The supporting evidence includes the following. First, the transport kinetic behavior of Tb was compared with that of the Tf moiety. The Tb was determined by inductively coupled plasma mass spectrometry and Tf was determined by fluorescence activated cell sorting analysis. The kinetic synchronization of internalization of both Tb and Tf into human leukemia K562 cells demonstrated the Tb(2)Tf complex was transported into cells as a whole. Second, using confocal laser scanning microscopy, we observed the localization of Tb(2)Tf in the cell. This showed that the internalized Tb(2)Tf was mostly situated in the same perinuclear region as diferric transferrin (Fe(2)Tf). In addition, pretreatment with pronase largely abolished the transport process of Tb(2)Tf. The relative fluorescence intensities representing the uptake of Tf into the cells decreased to about 16% and the cytosolic Tb content decreased to almost the same percentage as for Tf. Furthermore, the addition of Fe(2)Tf can effectively inhibit transport of Tb(2)Tf into K562 cells. Third, no significant decrease of cell viability was observed in the presence of Tb(2)Tf even for 24 or 48 h by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Moreover, prospects for the use of Tb(2)Tf as a multi-photon-excited microscopy probe in a living system are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.